Repeated dosing of botulinum toxin type A for upper limb spasticity following stroke

Neurology

Volumn 63, Issue 10, 2004, Pages 1971-1973

  Gordon, Mark Forrest ^a,g   Brashear, A ^b   Elovic, E ^c   Kassicieh, D ^d   Marciniak, C ^e   Liu, J ^f   Turkel, C ^f  

^a N Shore/Long Isl Jewish Hlth S ^*  (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JFK JOHNSON REHABILITATION INSTITUTE   (United States)

^d Neurol Res Institute of Sarasota   (United States)

^e REHABILITATION INSTITUTE OF CHICAGO   (United States)

^f ALLERGAN INC   (United States)

^g LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; PLACEBO;

ADULT; AGED; ARTICLE; ASTHENIA; BLEEDING; BURNING SENSATION; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISABILITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; ECCHYMOSIS; FEMALE; HUMAN; HYPERSENSITIVITY; HYPESTHESIA; INJECTION PAIN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MUSCLE HYPERTONIA; MUSCLE TONE; MUSCLE WEAKNESS; OPEN STUDY; ORTHOSTATIC HYPOTENSION; PAIN; PARESTHESIA; PRIORITY JOURNAL; SCORING SYSTEM; SIDE EFFECT; SPASTICITY; STROKE; TOOTH DISEASE; TREATMENT OUTCOME;

EID: 8844255485     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000144349.95487.91     Document Type: Article

References (10)

1. Lance JW. The control of muscle tone, reflexes, and movement: Robert Wartenberg Lecture. Neurology 1980;30:1303-1313.
2. Mayer NH, Esquenazi A, Childers MK. Common patterns of clinical motor dysfunction. Muscle Nerve Suppl 1997;6:S21-35.
3. Simpson DM, Alexander DN, O'Brien CF, et al. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology 1996;46:1306-1310.
4. Smith SJ, Ellis E, White S, Moore AP. A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury. Clin Rehabil 2000;14:5-13.
5. Brashear A, Gordon MF, Elovic E, et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med 2002;347:395-400.
6. Lagalla G, Danni M, Reiter F, Ceravolo MG, Provinciali L. Post-stroke spasticity management with repeated botulinum toxin injections in the upper limb. Am J Phys Med Rehabil 2000;79:377-384, 391-394 quiz.
7. Sampaio C, Ferreira JJ, Pinto AA, Crespo M, Ferro JM, Castro-Caldas A. Botulinum toxin type A for the treatment of arm and hand spasticity in stroke patients. Clin Rehabil 1997;11:3-7.
8. Brashear A, Zafonte R, Corcoran M, et al. Inter- and intrarater reliability of the Ashworth Scale and the Disability Assessment Scale in patients with upper-limb poststroke spasticity. Arch Phys Med Rehabil 2002;83:1349-1354.
9. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964;192:540-542.
10. Hatheway CL, Dang C. Immunogenicity of the neurotoxins of Clostridium botulinum. In: Jankovic J, Hallett M, eds. Therapy with botulinum toxin. New York: Marcel Dekker, 1994:93-107.